Author details

Full Name

Nicolas Stransky

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35927254	Molecular characterization of colorectal cancer related peritoneal metastatic disease.	Nat Commun	2022
31068700	Next-generation characterization of the Cancer Cell Line Encyclopedia.	Nature	2019
31639029	Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods.	Genome Biol	2019
31575541	First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.	Cancer Discov	2019
30559381	Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2019
30765874	TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.	British Journal of Cancer	2019
28297679	Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.	Cell Rep	2017
28658632	Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.	Cell Rep	2017
26181029	Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.	JAMA Oncol	2015
25932675	Targeting cancer with kinase inhibitors.	Journal of Clinical Investigation	2015
25776529	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.	Cancer Discovery	2015
24737027	A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.	Mol Cancer Ther	2014
25233892	Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.	Nat Commun	2014
25204415	The landscape of kinase fusions in cancer.	Nat Commun	2014
23269662	ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens.	Genome Res	2013
23770567	Mutational heterogeneity in cancer and the search for new cancer-associated genes.	Nature	2013
23993102	An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.	Cell	2013
22817889	A landscape of driver mutations in melanoma.	Cell	2012
22343534	Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.	Proc Natl Acad Sci U S A	2012
22622578	Melanoma genome sequencing reveals frequent PREX2 mutations.	Nature	2012
22460905	The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2012
22722202	Sequence analysis of mutations and translocations across breast cancer subtypes.	Nature	2012
22610119	Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.	Nat Genet	2012
21746896	Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.	Proc Natl Acad Sci U S A	2011
21173382	A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.	Journal of the National Cancer Institute	2011
20956946	Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.	Oncogene	2011
21892161	Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.	Nat Genet	2011
21764851	Nuclear factor I/B is an oncogene in small cell lung cancer.	Genes Dev	2011
21760589	Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.	Nature	2011
21666749	Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.	PLoS One	2011
21798893	The mutational landscape of head and neck squamous cell carcinoma.	Science	2011
20527025	Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.	J Pathol	2010
21107320	COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.	Nature	2010
18757432	Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.	Cancer Res	2008
17099711	Regional copy number-independent deregulation of transcription in cancer.	Nature Genetics	2006
16434445	Computation of recurrent minimal genomic alterations from array-CGH data.	Bioinformatics	2006
16820431	VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles.	Bioinformatics	2006
15735024	Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas.	Cancer Res	2005
16007141	Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.	Oncogene	2005
15262785	Selecting biomedical data sources according to user preferences.	Bioinformatics	2004
15381628	Analysis of array CGH data: from signal ratio to gain and loss of DNA regions.	Bioinformatics	2004